Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.

Autor: Nicole Ngo-Giang-Huong, Gonzague Jourdain, Billy Amzal, Pensiriwan Sang-a-gad, Rittha Lertkoonalak, Naree Eiamsirikit, Somboon Tansuphasawasdikul, Yuwadee Buranawanitchakorn, Naruepon Yutthakasemsunt, Sripetcharat Mekviwattanawong, Kenneth McIntosh, Marc Lallemant, Program for HIV Prevention and Treatment (PHPT) study group

Publikováno v: PLoS ONE, Vol 6, Iss 11, p e27427 (2011)

WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. F

Externí odkaz: https://doaj.org/article/ec8cfed01951462fb579c9ad34cd653f

Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand

Autor: Chureeratana Bowonwatanuwong, Panita Pathipvanich, Prattana Leenasirimakul, Kosit Tantinam, Rittha Lertkoonalak, Somboon Tansuphasawasdikul, Naruepon Yutthakasemsunt, Pacharee Kantipong, Prateung Liampongsabuddhi, Rattakarn Paramee, Nuananong Luekamlung, Isabelle Heard, Chaiwat Putiyanun, Nicole Ngo-Giang-Huong, Sinart Prommas, Rucha Kongpanichkul, Sophie Le Coeur, Sunida Panna, Aram Limtrakul, Diane Le Pluart, Nantasak Chotivanich, Virat Klinbuayaem, Pensiriwan Sang-a-gad, Céline Gallot, Sudanee Buranabanjasatean, Florence Brunet-Possenti, Tristan Delory, Myrtille Prouté, Guttiga Halue, Pakorn Wittayapraparat, Florence Fayard, Alexandre Blake, Samreung Rangdaeng, Wanmanee Matanasarawut, Naree Eiamsirikit, Métrey H. Tiv, Pornnapa Suriyachai, Prapap Yuthavisuthi, Kevin Zarca, Gonzague Jourdain, Fadia Dib, Tapnarong Jarupanich, Suchart Thongpaen, Nusra Puarattana-Aroonkorn, Thomas Althaus, Alice Desbiolles, Sookchai Theansavettrakul, Marc Lallemant, Apichat Chutanunta, Sukit Banchongkit

Publikováno v: Journal of Infection
Journal of Infection, 2017, 74 (5), pp.501-511. ⟨10.1016/j.jinf.2017.02.007⟩

International audience; OBJECTIVES: To estimate the prevalence and factors associated with Human Papillomavirus (HPV) infection, HPV genotypes and cytological/histological high-grade (HSIL+/CIN2+) lesions. METHODS: We conducted a cross-sectional stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972f99ad92503c627ae659eee659e607
https://pubmed.ncbi.nlm.nih.gov/28254419

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand

Autor: Panita Pathipvanich, Chureeratana Bowonwatanuwong, Yuwadee Buranawanitchakorn, Suporn Koetsawang, Wasna Sirirungsi, Luc Decker, Gonzague Jourdain, Marc Lallemant, Apichat Chutanunta, Sukit Banchongkit, Sophie Le Cœur, Guttiga Halue, Sylvaine Barbier, Pensiriwan Sang-a-gad, Sudanee Buranabanjasatean, Baptiste Leurent, Somboon Tansuphasawasdikul, Rittha Lertkoonalak, Federica Fregonese, Nuananong Luekamlung, Kenneth McIntosh, Sombat Thanprasertsuk, Naree Eiamsirikit, Narong Winiyakul, Naruepon Yutthakasemsunt, Patrinee Traisathit, Pakorn Wittayapraparat, Srisuda Thongbuaban, Phpt study team, Malee Techapornroong, Tim R. Cressey, Nicole Ngo-Giang-Huong, Pacharee Kantipong, Virat Klinbuayaem, Intira Jeannie Collins, Prattana Leenasirimakul, Ampaipith Nilmanat

Publikováno v: PLoS Medicine, Vol 10, Iss 8, p e1001494 (2013)
PLoS Medicine
PLoS Medicine, Public Library of Science, 2013, 10 (8), pp.e1001494. ⟨10.1371/journal.pmed.1001494⟩
PLoS Medicine, 2013, 10 (8), pp.e1001494. ⟨10.1371/journal.pmed.1001494⟩

Using a randomized controlled trial, Marc Lallemant and colleagues ask if a CD4-based monitoring and treatment switching strategy provides a similar clinical outcome compared to the standard viral load-based strategy for adults with HIV in Thailand.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ba44467aaf8afc0181cfd517035f53
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23940461/?tool=EBI